"The Duke Adult Blood and Marrow Transplant clinic provides outpatient transplant services to people with a blood cancer or other life-threatening diseases."

During the past decade, Duke University Adult Bone Marrow Transplant Clinic conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke University Adult Bone Marrow Transplant Clinic" #1 sponsor was "Duke University" with 2 trials, followed by "Joanne Kurtzberg, MD" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Michael Pulsipher, MD" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University Adult Bone Marrow Transplant Clinic" #1 collaborator was "Aldagen" with 1 trials as a collaborator, "Mereo BioPharma" with 1 trials as a collaborator, "Miltenyi Biomedicine GmbH" with 1 trials as a collaborator and "National Center for Advancing Translational Sciences (NCATS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Duke University Adult Bone Marrow Transplant Clinic" are "Hematologic Malignancy" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Aplastic Anemia" (1 trials), "Blood Disorders" (1 trials) and "Chronic Myelomonocytic Leukemia" (1 trials). Many other conditions were trialed in "Duke University Adult Bone Marrow Transplant Clinic" in a lesser frequency.

Most popular intervention types in "Duke University Adult Bone Marrow Transplant Clinic" are "Drug" (6 trials), "Biological" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALD-601" (1 trials), "Azacitidine" (1 trials), "BMS-936564" (1 trials), "Busulfan" (1 trials) and "Cell processing for TCRαβ+/CD19+ depletion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke University Adult Bone Marrow Transplant Clinic" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Duke University Adult Bone Marrow Transplant Clinic". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Duke University Adult Bone Marrow Transplant Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Duke University Adult Bone Marrow Transplant Clinic, 6 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".